Paradigm Capital Management Inc Tela Bio, Inc. Transaction History

Paradigm Capital Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$4.39 - $6.36 $3.25 Million - $4.71 Million	740,935 Added 143.8%	1,256,200 $5.9 Million
Q1 2024 May 15, 2024	BUY	$5.3 - $7.61 $88,854 - $127,581	16,765 Added 3.36%	515,265 $2.92 Million
Q4 2023 Feb 13, 2024	BUY	$4.5 - $7.51 $1.26 Million - $2.1 Million	279,000 Added 127.11%	498,500 $3.3 Million
Q3 2023 Nov 13, 2023	BUY	$7.85 - $10.68 $1.72 Million - $2.34 Million	219,500 New	219,500 $1.76 Million

18.3M

759K

100

Ticker TELA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 19,157,600
Market Cap $57.7M
Description
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall recon...

Get notified when there are updates to the investment portfolio of Paradigm Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Paradigm Capital Management Inc with notifications on news.